FDA Press Releases
FDA Press Releases
The feed below is an automatic RSS feed from the FDA website.
- FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following 3 Deaths
- FDA to Revoke 52 Obsolete Standards of Identity for Food Products
- FDA Issues Warning Letters to Firms Marketing Products Containing 7-Hydroxymitragynine
- FDA Approves Gardenia (Genipin) Blue Color Additive While Encouraging Faster Phase-Out of FD&C Red No. 3
- A Statement from FDA Commissioner Marty Makary, M.D., M.P.H: 100 Days of Embracing Gold-Standard Science, Transparency and Common Sense
- FDA Embraces Radical Transparency by Publishing Complete Response Letters
- FDA Encourages Industry Leaders to Streamline, Enhance Product Recall Communications to Safeguard Foods for Infants and Children
- FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor CAR T cell Immunotherapies
- FDA Halts New Clinical Trials That Export Americans’ Cells to Foreign Labs in Hostile Countries for Genetic Engineering
- FDA to Issue New Commissioner’s National Priority Vouchers to Companies Supporting U.S. National Interests
- FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
- FDA Takes Action to Address Data Integrity Concerns with Two Chinese Third-Party Testing Firms
- FDA and CBP Seize Nearly $34 Million Worth of Illegal E-Cigarettes During Joint Operation
- FDA takes steps to enhance state importation programs to help lower prescription drug prices
- FDA Clears First Blood Test Used in Diagnosing Alzheimer’s Disease